SGLT2 inhibitor monotherapy alleviates hyperglycemia in heredity severe insulin resistance syndromeOACSTPCDMEDLINE
SGLT2 inhibitor monotherapy alleviates hyperglycemia in heredity severe insulin resistance syndrome
Huixuan Wu;Junaid Iqbal;Long Li;Hongli Jiang;Chen Chao;Meibiao Zhang;Ou Li;Houde Zhou
Department of Metabolism and Endocrinology,National Clinical Research Center for Metabolic Diseases,Hunan Provincial Key Laboratory for Metabolic Bone Diseases,Key Laboratory of Diabetes Immunology,Ministry of Education,The Second Xiangya Hospital of Central South University,Changsha,Hunan 410011,ChinaDepartment of Endocrinology and Metabolism,The First People's Hospital of Huaihua,Huaihua,Hunan 418000,ChinaDepartment of Metabolism and Endocrinology,San-Sui County Traditional Chinese Medicine Hospital,Qiandongnan Miao and Dong Autonomous Prefecture,Guizhou 556000,China
《中华医学杂志（英文版）》 2024 (011)
1372-1374 / 3
This work was supported by grants from the National Natural Science Foundation of China(Nos.8217033609,81770880,and 81970762),the Science & Technology Department of Hunan Province(Nos.2020SK2080 and 2015JC3012),and the Science & Technology Department of Changsha City(Nos.k1906019 and kq190111).
评论